Stay updated on Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.

Latest updates to the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page
- Check6 days agoChange DetectedThe page has been updated to reflect an increase in study locations from 170 to 171, with several specific location details and contact information being modified. Notably, the contact person for Site 144 has changed from Evagelos Coskinas to Gerald Maguire.SummaryDifference4%
- Check13 days agoChange DetectedThe page now lists 170 locations for the study, an increase from 169, and includes updated contact information for several sites, including the addition of new locations in various states and countries. Notably, the name of the contact person for Site 130 has changed from Gerald Maguire to Diane Highum.SummaryDifference28%
- Check21 days agoChange DetectedThe page has been updated to reflect an increase in study locations from 168 to 169, with new recruiting sites added in Fort Worth, Texas, and Fukuoka and Aichi-Ken, Japan. Additionally, the status of the study has changed from 'not yet recruiting' to 'recruiting' for some locations.SummaryDifference2%
- Check28 days agoChange DetectedThe page now indicates that the study has increased from 167 to 168 locations, and it includes a new recruiting site in Atlanta, Georgia, with contact information for Elyssa Barron. Additionally, there are updates regarding service performance due to heavy traffic.SummaryDifference1%
- Check35 days agoChange DetectedThe study has expanded to 167 locations and is now actively recruiting, with several new sites added across the United States and Europe, including notable institutions like Stanford University School of Medicine and various clinical research centers.SummaryDifference14%
- Check42 days agoChange DetectedThe study has expanded to include 166 locations, with several new sites added in Bulgaria, Czechia, and Japan, while 155 locations have been removed, indicating a significant update in the study's scope.SummaryDifference12%
Stay in the know with updates to Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.